Cite
Studies from Zhejiang University Describe New Findings in Parkinson's Disease (Elevated Serum Anti- Saccharomyces Cerevisiae Antibody Accompanied By Gut Mycobiota Dysbiosis As a Biomarker of Diagnosis In Patients With De Novo...).
MLA
“Studies from Zhejiang University Describe New Findings in Parkinson’s Disease (Elevated Serum Anti- Saccharomyces Cerevisiae Antibody Accompanied By Gut Mycobiota Dysbiosis As a Biomarker of Diagnosis In Patients With De Novo...).” Gastroenterology Week, Nov. 2024, p. 856. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180604038&authtype=sso&custid=ns315887.
APA
Studies from Zhejiang University Describe New Findings in Parkinson’s Disease (Elevated Serum Anti- Saccharomyces Cerevisiae Antibody Accompanied By Gut Mycobiota Dysbiosis As a Biomarker of Diagnosis In Patients With De Novo...). (2024). Gastroenterology Week, 856.
Chicago
“Studies from Zhejiang University Describe New Findings in Parkinson’s Disease (Elevated Serum Anti- Saccharomyces Cerevisiae Antibody Accompanied By Gut Mycobiota Dysbiosis As a Biomarker of Diagnosis In Patients With De Novo...).” 2024. Gastroenterology Week, November, 856. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180604038&authtype=sso&custid=ns315887.